CareCloud (CCLD) Projected to Post Earnings on Tuesday

Key Points

• CareCloud (NASDAQ: CCLD) is expected to release its Q2 2025 earnings on August 5th, with analysts forecasting earnings of $0.08 per share and revenue of $27.19 million.
• In its last earnings report, CareCloud missed analysts' expectations, reporting $0.05 EPS against a consensus of $0.09, while revenue surpassed estimates at $27.60 million.
• CareCloud's stock has seen fluctuations, reaching a 12-month high of $4.84 and a low of $1.14, with a current market cap of $100.51 million and a PE ratio of -10.84.

CareCloud (NASDAQ:CCLD - Get Free Report) is expected to announce its Q2 2025 earnings results before the market opens on Tuesday, August 5th. Analysts expect the company to announce earnings of $0.08 per share and revenue of $27.19 million for the quarter. CareCloud has set its FY 2025 guidance at 0.100-0.130 EPS.

CareCloud (NASDAQ:CCLD - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). CareCloud had a net margin of 8.92% and a return on equity of 24.08%. The business had revenue of $27.60 million during the quarter, compared to analysts' expectations of $25.94 million. On average, analysts expect CareCloud to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

CareCloud Price Performance

Shares of CCLD traded down $0.07 during mid-day trading on Friday, reaching $2.31. The company's stock had a trading volume of 26,841 shares, compared to its average volume of 609,292. CareCloud has a 12-month low of $1.14 and a 12-month high of $4.84. The stock has a market cap of $97.59 million, a PE ratio of -10.57 and a beta of 2.06. The company's 50 day moving average is $2.31 and its 200 day moving average is $2.36.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on CCLD shares. Wall Street Zen upgraded CareCloud from a "hold" rating to a "buy" rating in a report on Sunday, July 13th. Roth Capital restated a "neutral" rating on shares of CareCloud in a research note on Tuesday, May 6th.

Insider Transactions at CareCloud

In related news, Director John N. Daly sold 15,000 shares of the firm's stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $2.11, for a total transaction of $31,650.00. Following the transaction, the director owned 61,750 shares in the company, valued at $130,292.50. This trade represents a 19.54% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 14.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in CareCloud stock. Acadian Asset Management LLC increased its position in shares of CareCloud, Inc. (NASDAQ:CCLD - Free Report) by 481.9% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 203,053 shares of the company's stock after buying an additional 168,156 shares during the quarter. Acadian Asset Management LLC owned about 0.48% of CareCloud worth $280,000 as of its most recent SEC filing. 10.16% of the stock is owned by institutional investors.

About CareCloud

CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.